EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model

Formulation of epidermal growth factor receptor-targeted redox-responsive gelatin nanoparticles encapsulating gemcitabine through disulfide conjugation for systemic administration and treatment in a surgical orthotopic pancreatic cancer murine model.166